On the other hand, it is also proposed that higher GM-CSF in the serum is related to the BC metastasis and increased production of GM-CSF in cancer patients (probably due to inflammatory milieu, i.e., in response to TNF-α and LPS), supports angiogenesis, and promotes tumor growth and progression [123,124]. This evidence concerns the gene CSF2 and breast cancer.